Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement.

NCT ID: NCT06238960

Last Updated: 2025-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-10

Study Completion Date

2026-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Total arthroplasty (THA) is the treatment of choice for severe osteoarthritis of the hip joint. Following this type of intervention, a multidisciplinary rehabilitation approach allows you to reduce pain and improve the ability to carry out activities of daily living (ADL), but it is not clear what the optimal rehabilitation program is. Recently, the use of telerehabilitation has increased over the years. Specifically, in treatment of patients following THA surgery, telerehabilitation is able to give similar results to the treatment performed in person terms of pain and function. The aim of this study is to verify whether telerehabilitation associated with In-person treatment is comparable in terms of pain, recovery functionality and patient participation and satisfaction, compared to those provided by rehabilitation alone in the presence of patients undergoing THA surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Replacement Telerehabilitation Physiotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Telerehabilitation

the patients who will be randomized and subjected to the experimental treatment will undergo a physiotherapy treatment with a biweekly frequency which will be started at the same times as the standard group.

After the sixth session, the process will continue through telerehabilitation until the end of outpatient treatment.

Group Type EXPERIMENTAL

Telerehabilitation

Intervention Type OTHER

the patient will undergo 10 session of tele rehabilitation in continuity with traditional physiotherapy

traditional physiotherapy

Patients who will be randomized and subjected to standard treatment (usual care at our clinic) will undergo physiotherapy treatment on a bi-weekly basis in person.

Group Type ACTIVE_COMPARATOR

Traditional rehabilitation

Intervention Type OTHER

the patient will undergo 16 session of outpatient physiotherapy rehabilitation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telerehabilitation

the patient will undergo 10 session of tele rehabilitation in continuity with traditional physiotherapy

Intervention Type OTHER

Traditional rehabilitation

the patient will undergo 16 session of outpatient physiotherapy rehabilitation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having undergone total hip replacement surgery (THA)
* Start outpatient treatment within 7 days of discharge from the Orthopedic Department
* Age between 50 and 80 years.
* Continuation of rehabilitation treatments at the IOR Physical Medicine and Rehabilitation service in Argenta.
* The subjects or any caregivers must be able to use an electronic device (PC, tablet, smartphone).

Exclusion Criteria

* patients undergoing revision of previous prosthesis surgery
* difficulty understanding the Italian language/language barrier
* unavailability stable wi-fi connection by the patient
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istituto Ortopedico Rizzoli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Istituto ortopedico Rizzoli

Bologna, Italia, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marco Ruggiero

Role: CONTACT

3382001089

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marco Ruggiero

Role: primary

3382001089

References

Explore related publications, articles, or registry entries linked to this study.

Sadiq S, Ahmad A, Ahmed A, Khan I, Asim HM, Aziz A. Role of tele-rehabilitation in patients following total hip replacement: Systematic review of clinical trials. J Pak Med Assoc. 2022 Jan;72(1):101-107. doi: 10.47391/JPMA.832.

Reference Type RESULT
PMID: 35099447 (View on PubMed)

Nelson M, Bourke M, Crossley K, Russell T. Telerehabilitation is non-inferior to usual care following total hip replacement - a randomized controlled non-inferiority trial. Physiotherapy. 2020 Jun;107:19-27. doi: 10.1016/j.physio.2019.06.006. Epub 2019 Jun 25.

Reference Type RESULT
PMID: 32026820 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TELERIABPTA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PT vs no PT Following THA
NCT02687945 COMPLETED NA